MedWatch·Financial report·Business & finance·2d agoNordea raises Demant price target on strong US demand for Oticon ZealNordea raises its price target for Demant, citing strong US demand for the Oticon Zeal hearing aid and signs of improvement in US market growth.＋Save
MedWatch·Financial report·Business & finance·2w agoGN shares rise as major bank sees potential for significant revaluationSwedish bank SEB upgrades GN shares, citing the upcoming Evolve3 headset launch as a catalyst expected to return GN's Enterprise division to a growth trajectory and drive significant stock revaluation.＋Save
MedWatch·Industry news·Business & finance·2w agoHearing industry supplier changes CEO: Aims to triple the business in five yearsAuditdata's incoming CEO outlines a five-year plan to triple the business by trimming the product lineup, expanding AI capabilities, and leveraging new American ownership for global growth.＋Save
MedWatch·Industry news·Business & finance·3w agoWSA chair withdraws demand for new CFO to have IPO experience: It's not decisiveWSA chair Lars Rasmussen supports the call for a new CFO with IPO experience but downplays it as decisive, citing Peter Bøggild's background at Novo as more relevant than specific stock market experience.＋Save
MedWatch·Industry news·Business & finance·3w agoWSA recruits new CFO from NovoWS Audiology has appointed Peter Bøggild, recruited from Novo, as its new CFO, with the hire seen as a step toward a potential public listing of the company.＋Save
MedWatch·Industry news·Business & finance·3w agoSonova aims to be a key player in the Danish hearing health sectorSonova is positioning itself as a key player in Denmark's hearing health sector by engaging with public digitization projects, new clinical workflows, and training programs to address the country's audiology capacity crisis.＋Save
MedWatch·Financial report·Business & finance·4w agoBanks say GN's Amplifon stake is likely to yield unexpected profitsThree major banks estimate GN's stake in Amplifon could reach DKK 7bn (USD 1.1bn) in value if Amplifon's stock price continues to rise, signalling unexpected investment gains.＋Save
MedWatch·Industry news·Telehealth·4w agoSonova targets first iPhone generation with more flexible hearing-care modelSonova is developing a more flexible hearing-care delivery model targeting iPhone-generation consumers, enabling movement between hospitals, clinics, home visits, and remote services rather than a single standardised care pathway.＋Save
MedWatch·Industry news·Business & finance·4w agoFounder sells fast-growing hearing care company to Sonova four years after launchSonova has acquired Høreservice Danmark, a Danish mobile hearing care provider founded roughly four years ago that grew to 25 vehicles and over 50 employees, with plans to expand the model.＋Save
MedWatch·Industry news·Business & finance·4w agoSonova Acquires Danish High-Growth CompanySwiss hearing-health company Sonova is acquiring Høreservice Danmark, a Danish operator of 25 mobile hearing clinics, with plans to expand the home-based hearing care model internationally.＋Save
MedWatch·Industry news·Business & finance·4w agoBankrupt hearing aid company Audientes under police investigationHearing aid company Audientes, which has filed for bankruptcy, is under police investigation; authorities have not disclosed the nature of the investigation.＋Save
MedWatch·Industry news·OTC / consumer·5w agoElehear sees good growth in crisis-ridden hearing aid marketElehear reports growth in the OTC hearing aid market and launches a tele-audiology service aimed at bringing clinic-like care to OTC users, contrasting with Danish competitors scaling back their OTC offerings.＋Save
MedWatch·Industry news·Business & finance·5w agoProfessors: WSA's vacant CFO position will delay the IPOProfessors warn that WSA's vacant CFO position may delay its IPO, while WSA CEO Jan Mäkelä has previously stated the CFO departure would not affect the timing of a potential public offering.＋Save
MedWatch·Industry news·Business & finance·6w agoHearing aid manufacturer falls behind in the growth race: A sign of fierce competitionAn unnamed hearing aid manufacturer is lagging in market growth while competitors Demant, Sonova, and GN accelerate; the company's CEO outlines plans for a comeback via a new product platform.＋Save
MedWatch·Industry news·Business & finance·6w agoWSA to be without a CFO in four days – will not affect stock market plansWSA's CFO position will be vacant in four days as the search for a successor drags on; the company's CEO says the process is near completion and stock market plans will not be affected.＋Save
MedWatch·Industry news·Business & finance·6w agoWS Audiology is still looking for a new CFOWS Audiology is still searching for a new CFO following the announced departure of Chief Financial Officer Marianne Wiinholt in June.＋Save
MedWatch·Financial report·Business & finance·6w agoWS Audiology returns to positive growth and narrows outlookWS Audiology revised its organic growth outlook to 1–2% after returning to positive growth, narrowing its previous forecast range of 0–4%.＋Save
MedWatch·Industry news·Hearing aids·6w agoAfter three-year wait, new platform aims to put WSA back on topWS Audiology's new AI-powered Signia platform aims to close the competitive gap with Demant, GN, and Sonova while validating its dual-brand strategy.＋Save
MedWatch·Product announcement·Hearing aids·6w agoSonova launches AI-powered product platform featuring flagship productSonova launches its new AI-powered hearing aid platform with the Phonak Audéo EON as the flagship receiver-in-canal product.＋Save
MedWatch·Industry news·Business & finance·6w agoGN CEO rejects criticism of “scandalous” sale: “I have great confidence in the board’s decision”GN CEO Peter Karlströmer defends the board's decision to sell GN Hearing amid investor criticism, commenting on the Amplifon process and the outlook for GN Hearing employees.＋Save
MedWatch·Industry news·Business & finance·6w agoGN must swallow major loss on stake in US audio company: “Unfortunate and frustrating”GN is writing off its 9% stake in US audio company LXE Hearing to zero after the partner failed to meet its obligations, resulting in a major financial loss.＋Save
MedWatch·Industry news·Business & finance·6w agoGN delays online business profit target againGN's CEO acknowledges that the online hearing business Jabraenhance.com is near break-even but has pushed back its profitability target by several quarters.＋Save
MedWatch·Financial report·Business & finance·6w agoMore US retail rivals pressure GN: "Larger than anticipated decline"GN's CEO Peter Karlströmer attributed a larger-than-anticipated Q2 revenue decline to US retail competition and called it temporary, pinning recovery hopes on a new flagship product, while rival Demant raised its financial guidance.＋Save
MedWatch·Financial report·Business & finance·6w agoGN's hearing aids experience a decline in sales and earningsGN's hearing aid division reported a decline in both revenue and operating profit in Q2, attributed to challenges in the US market.＋Save
MedWatch·Industry news·Business & finance·7w agoDemant closes KIND factory in Germany: “The technology was outdated”Demant is closing its KIND hearing aid factory in Kölleda, Germany, citing outdated technology; the closure affects ~200 employees and will be recorded as special items in Demant's cost-saving and integration program.＋Save
MedWatch·Industry news·OTC / consumer·7w agoSamsung gets FDA approval – takes leap into US OTC marketSamsung has received FDA approval to enter the US over-the-counter hearing aid market, a move analysts at Carnegie describe as a potential driver pushing consumers toward traditional hearing aids.＋Save
MedWatch·Industry news·Business & finance·7w agoDemant expects hefty refund: “Now, the net effect of customs duties is the other way around”Demant now expects to receive a refund covering nearly all customs duties previously paid under Trump-era tariffs, which primarily affected the company's diagnostics business, with reimbursement anticipated in H2 of the year.＋Save
MedWatch·Industry news·Business & finance·7w agoDemant buys Amplifon’s UK chain: “We decided to make this a major project”Demant acquired Amplifon's UK retail clinic chain, strengthening its direct-to-consumer hearing care presence in the UK market despite the deal appearing as a minor line item in financial statements.＋Save
MedWatch·Industry news·Business & finance·8w agoDemant CEO steps up efforts despite tough competition ahead: “We’re not done yet”Demant CEO Søren Nielsen expresses confidence in the company's revised growth forecast amid intensifying competition from new product launches by rival hearing-aid manufacturers.＋Save
